2 years ago

Resurrect Bio Secures £1.61 Million Funding to Enhance Crop Disease Resistance

  • Resurrect Bio, a London-based biotechnology startup focused on the agriculture industry, raised £1.61 million in funding led by SynBioVen

  • The company intends to use the funds to accelerate product development and strengthen its underlying disease resistance trait-discovery platform

  • Resurrect Bio is a spin-out company of The Sainsbury Laboratory in Norwich that leverages gene editing techniques to make crops more resistant to disease

  • They use computational biology, AI, and synthetic biology to identify and resurrect native disease resistance genes.

      • ProblemAgriculture

      "Farmers are constantly battling crop diseases, which leads to significant losses in yield and revenue. Current solutions are often ineffective or expensive, leaving farmers with limited options."

      Solution

      "Resurrect Bio utilizes gene editing techniques to enhance the natural disease resistance of crops. They identify and revive dormant genes within the crops' genetic makeup, making them more resilient to disease without relying on external interventions."

      Covered on